NDT Pharmaceuticals Inc. (NDTP)
OTC
Healthcare
Biotechnology
$0.37
▲ +0.00%
Market Cap
$59.2M
Sector
Healthcare
Industry
Biotechnology
Beta
0.00
52-Wk Range
0.243-2.1
CEO
James Hovis
Country
US
Currency
USD
NDT Pharmaceuticals Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vienna, VA, US. The stock last traded at $0.37, up 0.00% on the session, giving a market capitalisation of $59.2M. On trailing twelve-month figures it carries a trailing P/E of -72.55, a net margin of -366.4%. Its beta of 0.00 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-72.55
Price / Sales
212.60
Price / Book
1.87
EV / EBITDA
-94.69
Gross margin
-145.0%
Operating margin
-365.6%
Net margin
-366.4%
Return on equity
—
Debt / equity
0.02
Current ratio
6.55
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
0
IPO date
2008-01-22
Headquarters
Vienna, VA, US
About NDT Pharmaceuticals Inc.
NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.
Comparable companies
NDT Pharmaceuticals Inc. is most often compared with the following Healthcare names:
More research on NDTP
Open full interactive analysis & DCF →